Global Pharmaceutical Intermediates Market, By Intermediate Type (Bulk Intermediate, Chemical Intermediate), By Application (Anti-Infective Drugs, Analgesics, Antidiabetic Drugs, Cardiovascular Drugs, Antimicrobial Drugs, Anti-inflammatory Drugs, Others),

Global Pharmaceutical Intermediates Market, By Intermediate Type (Bulk Intermediate, Chemical Intermediate), By Application (Anti-Infective Drugs, Analgesics, Antidiabetic Drugs, Cardiovascular Drugs, Antimicrobial Drugs, Anti-inflammatory Drugs, Others), By End User (Biopharmaceutical Companies, CMO, CRO, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)


The pharmaceutical intermediates market has been witnessing significant growth over the past few years. Pharmaceutical intermediates are chemical compounds produced during the various steps of pharmaceutical drug synthesis. They help in efficiently manufacturing drugs in large quantities with minimum resources. Rising prevalence of chronic diseases along with increasing R&D investments by pharmaceutical companies are fueling the demand for intermediates. Additionally, the growing geriatric population worldwide prone to chronic medical conditions is positively influencing the market growth. However, strict regulatory frameworks for the approval of new intermediates and high capital requirement for setting up manufacturing facilities are some challenges restraining the market growth. Overall, the widespread use of intermediates in streamlining drug production processes indicates huge opportunities for market expansion in the coming years.

Market Dynamics:

The global pharmaceutical intermediates market is primarily driven by the growing incidence of lifestyle-induced chronic diseases like diabetes, cancer, cardiovascular disorders, etc. Favorable government policies supporting local drug manufacturing is another key factor pushing the market growth. On the other hand, factors like high R&D costs associated with developing novel intermediates and lengthy approval times from regulatory bodies are slowing the market progress. Also, intense competition among established players poses major challenge to new entrants. However, rising pharmaceutical outsourcing trends from developing countries present lucrative opportunities for market players. Continued technological innovations to develop safe and eco-friendly intermediates will further support the market expansion over the forecast period.

Key Features of the Study:
  • This report provides an in-depth analysis of the global pharmaceutical intermediates market, and provides market size (USD Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global pharmaceutical intermediates market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • The key companies covered as a part of this study include Evonik, Borregaard AS, Sudarshan Pharma, A.R. Life Science, Actylis, Saurav Chemicals Ltd., Lianhetech, Midas Pharma GmbH, Sanofi , BASF SE, Chiracon GmbH, Lonza, Chemcon Speciality Chemicals Limited., Modepro India Pvt. Ltd., Lifechem Pharma, Sarex, and LANXESS.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global pharmaceutical intermediates market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmaceutical intermediates market.
Detailed Segmentation:
  • Intermediate Type:
  • Bulk Intermediate
  • Chemical Intermediate
  • Application:
  • Anti-Infective Drugs
  • Analgesics
  • Antidiabetic Drugs
  • Cardiovascular Drugs
  • Antimicrobial Drugs
  • Anti-inflammatory Drugs
  • Others
  • End User:
  • Biopharmaceutical Companies
  • CMO
  • CRO
  • Others
  • Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
  • Company Profiles:
  • Evonik
  • Borregaard AS
  • Sudarshan Pharma
  • R. Life Science
  • Actylis
  • Saurav Chemicals Ltd.
  • Lianhetech
  • Midas Pharma GmbH
  • Sanofi
  • BASF SE
  • Chiracon GmbH
  • Lonza
  • Chemcon Speciality Chemicals Limited.
  • Modepro India Pvt. Ltd.
  • Lifechem Pharma
  • Sarex
  • LANXESS


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Overview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Intermediate Type
Market Snapshot, By Application
Market Snapshot, By End User
Market Snapshot, By Region
Market Scenario - Conservative, Likely, Opportunistic
Market Opportunity Map
3. Key Insights
Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Technological Advancements
Merger, Acquisition and Collaboration Scenario
Regulatory Scenario
Pricing Analysis
COVID-19 Impact Analysis
Healthcare Spending, by Country
Manufacturing Capacities
Distributors Landscape
4. Global Pharmaceutical Intermediates Market, By Intermediate Type, 2019 - 2031 (US$ Billion)
Introduction
Market Share (%) Analysis, 2024, 2027 & 2031
Market Y-o-Y Growth Comparison (%), 2019 - 2031
Segment Trends
Bulk Intermediate, 2019 - 2031(US$ Billion)
Introduction
Market Size and Forecast, 2019 - 2031, (US$ Billion)
Chemical Intermediate, 2019 - 2031(US$ Billion)
Introduction
Market Size and Forecast, 2019 - 2031, (US$ Billion)
5. Global Pharmaceutical Intermediates Market, By Application, 2019 - 2031 (US$ Billion)
Introduction
Market Share (%) Analysis, 2024, 2027 & 2031
Market Y-o-Y Growth Comparison (%), 2019 - 2031
Segment Trends
Anti-Infective Drugs, 2019 - 2031(US$ Billion)
Introduction
Market Size and Forecast, 2019 - 2031, (US$ Billion)
Analgesics, 2019 - 2031(US$ Billion)
Introduction
Market Size and Forecast, 2019 - 2031, (US$ Billion)
Antidiabetic Drugs, 2019 - 2031(US$ Billion)
Introduction
Market Size and Forecast, 2019 - 2031, (US$ Billion)
Cardiovascular Drugs, 2019 - 2031(US$ Billion)
Introduction
Market Size and Forecast, 2019 - 2031, (US$ Billion)
Antimicrobial Drugs, 2019 - 2031(US$ Billion)
Introduction
Market Size and Forecast, 2019 - 2031, (US$ Billion)
Anti-inflammatory Drugs, 2019 - 2031(US$ Billion)
Introduction
Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others, 2019 - 2031(US$ Billion)
Introduction
Market Size and Forecast, 2019 - 2031, (US$ Billion)
6. Global Pharmaceutical Intermediates Market, By End User, 2019 - 2031 (US$ Billion)
Introduction
Market Share (%) Analysis, 2024, 2027 & 2031
Market Y-o-Y Growth Comparison (%), 2019 - 2031
Segment Trends
Biopharmaceutical Companies, 2019 - 2031(US$ Billion)
Introduction
Market Size and Forecast, 2019 - 2031, (US$ Billion)
CMO, 2019 - 2031(US$ Billion)
Introduction
Market Size and Forecast, 2019 - 2031, (US$ Billion)
CRO, 2019 - 2031(US$ Billion)
Introduction
Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others, 2019 - 2031(US$ Billion)
Introduction
Market Size and Forecast, 2019 - 2031, (US$ Billion)
7. Global Pharmaceutical Intermediates Market, By Region, 2019 - 2031 (US$ Billion)
Introduction
Market Share (%) Analysis, 2024, 2027 & 2031, (US$ Billion)
Market Y-o-Y Growth Comparison (%), 2019 - 2031, (US$ Billion)
Regional Trends
North America
Introduction
Market Size and Forecast, By Intermediate Type, 2019 - 2031, (US$ Billion)
Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, By Intermediate Type, 2019 - 2031, (US$ Billion)
Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest Of Europe
Asia Pacific
Introduction
Market Size and Forecast, By Intermediate Type, 2019 - 2031, (US$ Billion)
Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
China
India
Japan
Australia
South Korea
Asean
Rest Of Asia Pacific
Latin America
Introduction
Market Size and Forecast, By Intermediate Type, 2019 - 2031, (US$ Billion)
Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, By Intermediate Type, 2019 - 2031, (US$ Billion)
Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
GCC
Israel
Rest of the Middle East
Africa
Introduction
Market Size and Forecast, By Intermediate Type, 2019 - 2031, (US$ Billion)
Market Size and Forecast, By Application, 2019 - 2031, (US$ Billion)
Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
Market Size and Forecast, By Country/Region, 2019 - 2031, (US$ Billion)
South Africa
North Africa
Central Africa
8. Company Profiles - Global Pharmaceutical Intermediates Market
Evonik
Company Overview
Product/Service Portfolio
Financial Performance
Recent Developments/Updates
Strategic Overview
Borregaard AS
Sudarshan Pharma
A.R. Life Science
Actylis
Saurav Chemicals Ltd.
Lianhetech
Midas Pharma GmbH
Sanofi
BASF SE
Chiracon GmbH
Lonza
Chemcon Speciality Chemicals Limited.
Modepro India Pvt. Ltd.
Lifechem Pharma
Sarex
LANXESS
9. References and Research Methodology
References
Research Methodology
About us and Sales Contact

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings